Shares of nanocap pharma Cara Therapeutics (NASDAQ:CARA) added ~11% in the premarket on Wednesday after the company agreed to merge with privately held biopharma Tvardi Therapeutics in an all-stock ...
(RTTNews) - Cara Therapeutics, Inc. (CARA) Monday announced it will focus its resources on the oral difelikefalin Phase 2/3 clinical program in notalgia paresthetica (NP) and significantly reduce its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results